AstraZeneca | Należności Handlowe



Trade Debtors Zmiana Data
AbbVie USD 10.92B 553M 2024-12
Alcon AG USD 2.08B 314M 2024-12
Almirall EUR 178.14M 31.11M 2024-06
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.83B 1.28B 2024-12
Autolus Therapeutics Ltd 43.28M 5.29M 2024-09
Bayer EUR 12.5B 1.33B 2024-12
Biogen USD 1.87B 119.3M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Fresenius EUR 3.5B 317M 2024-12
Fresenius Medical Care EUR 3.37B 123M 2024-12
Galapagos EUR 87.36M 133K 2024-12
Genmab DKK 6.69B 381M 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
GlaxoSmithKline GBP 7.32B 542M 2024-12
GRIFOLS EUR 871.58M 135.79M 2024-12
Haleon 2.15B 70M 2024-12
Hikma Pharmaceutical USD 965M 92M 2024-06
Indivior 271M 10M 2024-09
Lonza CHF 2B 406M 2024-12
Merck EUR 4.46B 381M 2024-09
Merck USD 11.12B 1.06B 2024-12
Novartis USD 9B 854M 2024-12
Orion EUR 392.2M 11.1M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Philips EUR 3.77B 170M 2024-12
Recordati EUR 576.98M 15.22M 2024-09
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 8.8B 2.24B 2024-06
UCB EUR 1.42B 132M 2024-06



AstraZeneca Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.